| Sources | Names Used |
|---|---|
| CTRPv2 | vorinostat:navitoclax (4:1 mol/mol) |
| PharmacoGx | vorinostat:navitoclax (4:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | LMNA | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | SHC1 | CTRPv2 | pan-cancer | AAC | -0.2 | 6e-08 |
| mRNA | DAP3 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
| mRNA | S100A11 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
| mRNA | NBPF14 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
